综述：Ivermectin for Prevention and Treatment of COVID-19 Infection
来源: fuz 于 2021-08-01 15:50:28
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical GuidelinesIvermectin for Prevention and Treatment of COVID-19... : American Journal of Therapeutics
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
Ivermectin for preventing and treating COVID-19 - PubMed
Authors' conclusions: Based on the current very low- to low-certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID-19. The completed studies are small and few are considered high quality. Several studies are underway that may produce clearer answers in review updates. Overall, the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID-19 outside of well-designed randomized trials.
Systematic review explores the effects of ivermectin in preventing and treating COVID-19
"The lack of good quality evidence on efficacy and safety of ivermectin arises from a study pool that consists mainly of small, insufficiently powered RCTs with overall limited quality regarding study design, conduct and reporting. Current evidence does not support using ivermectin for treating or preventing of COVID-19 unless they are part of well-designed randomized trials."
Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control studyRole of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study
ResultsIvermectin prophylaxis was taken by 76 controls and 41 cases. Two-dose ivermectin prophylaxis (AOR 0.27, 95% CI, 0.15–0.51) was associated with a 73% reduction of SARS-CoV-2 infection among healthcare workers for the following month. Those involved in physical activity (AOR 3.06 95% CI, 1.18–7.93) for more than an hour/day were more likely to contract SARS-CoV-2 infection. Type of household, COVID duty, single-dose ivermectin prophylaxis, vitamin-C prophylaxis and hydroxychloroquine prophylaxis were not associated with SARS-CoV-2 infection.
ConclusionTwo-dose ivermectin prophylaxis at a dose of 300 μg/kg with a gap of 72 hours was associated with a 73% reduction of SARS-CoV-2 infection among healthcare workers for the following month. Chemoprophylaxis has relevance in the containment of pandemic.
Goa prescribes Ivermectin for all above 18 to fight COVID-19 even as experts flag concern: All you need to know-Health News , Firstpost
‘Lower mortality...’: Goa govt defends Ivermectin’s efficacy against Covid-19
In defence of its decision to administer Ivermectin, an anti-parasitic medicine for the use as prophylaxis, to Covid-19 patients, the Goa government, in a statement, has claimed that the mortality rate is much lower in patients who take the medicine than those who don’t.
Why You Should Not Use Ivermectin to Treat or Prevent COVID-19
Here’s What You Need to Know about Ivermectin
- FDA has not approved ivermectin for use in treating or preventing COVID-19 in humans. Ivermectin tablets are approved at very specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an anti-viral (a drug for treating viruses).
- Taking large doses of this drug is dangerous and can cause serious harm.
- If you have a prescription for ivermectin for an FDA-approved use, get it from a legitimate source and take it exactly as prescribed.
- Never use medications intended for animals on yourself. Ivermectin preparations for animals are very different from those approved for humans.
EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trialsEMA advises against use of ivermectin for the prevention or treatment COVID-19 outside randomised clinical trials - European Medicines Agency，